Sino Biopharmaceutical | 1177 - Sales Revenues

Stock Price
6.06
Daily Change
-0.19 -3.04%
Monthly
-8.87%
Yearly
63.78%
Q1 Forecast
5.72

Sino Biopharmaceutical reported CNY17.57B in Sales Revenues for its fiscal semester ending in June of 2025.





Sales Change Date
Akebia Therapeutics USD 57.62M 1.14M Dec/2025
Alaunos Therapeutics USD 2K 2K Mar/2025
Avita Medical AUD 17.61M 805K Dec/2025
Cspc Pharmaceutical CNY 6.62B 358.95M Sep/2025
Dianthus Therapeutics USD 284K 112K Dec/2025
Ionis Pharmaceuticals USD 203M 46M Dec/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
Jiangsu Hengrui CNY 7.43B 1.17B Sep/2025
Moderna USD 678M 342M Dec/2025
Organon & Co USD 1.51B 90M Dec/2025
Revvity USD 772.06M 73.06M Dec/2025
Sino Biopharmaceutical CNY 17.57B 4.58B Jun/2025
Tectonic Therapeutic USD 0 0 Dec/2024
Viatris USD 3.7B 60M Dec/2025
Xeris Pharmaceuticals USD 74.38M 2.84M Sep/2025